Take the Direct Route to Commercialization in Canada


Why Canada: Is Canada an attractive market for global pharmaceutical manufacturers?

In addition to being among the top 10 pharmaceutical markets in the world, Sandra Anderson, Senior Vice President, Commercialization and Strategy, discusses why the Canadian pharmaceutical sector has a growing presence and what makes it so attractive to manufacturers.

Why Canada: How we help Pharmaceutical Manufacturers commercialize their products in Canada.

Not only does Innomar Strategies provide strategic advice and planning, but we also execute and implement all end-to-end commercialization services for companies launching a new therapy into the Canadian marketplace.

Related Videos
© 2024 MJH Life Sciences

All rights reserved.